Skip to content

Clinical trials

Hyperlipoproteinemia Type II trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Country / region: France Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20071
20122
20142
20151
20201
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Pfizer3
Hospices Civils de Lyon2
Novartis Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire, Amiens1
French Cardiology Society1
Genzyme, a Sanofi Company1
Institute of Cardiometabolism and Nutrition, France1
Nantes University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II16
Hypercholesterolemia6
Homozygous Familial Hypercholesterolemia3
Hyperlipidemias3
Atherosclerosis2
Aortic Valve Stenosis1
Cardiovascular Diseases1
Dyslipidemias1
Heart Failure1

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.